BRKR Bruker Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR

Price (delayed)

$66.84

Market cap

$9.71B

P/E Ratio

24.31

Dividend/share

$0.2

EPS

$2.75

Enterprise value

$10.84B

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions ...

Highlights
BRKR's price to earnings (P/E) is 38% lower than its 5-year quarterly average of 37.5 and 23% lower than its last 4 quarters average of 30.5
BRKR's equity is up by 20% YoY and by 2.8% QoQ
BRKR's EPS is up by 30% year-on-year but it is down by 6% since the previous quarter
The net income is up by 29% year-on-year but it has declined by 6% since the previous quarter
The quick ratio has decreased by 24% YoY and by 12% from the previous quarter
Bruker's debt has increased by 19% YoY and by 8% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bruker.com
Peers: TMO BIO WAT A

Key stats

What are the main financial stats of BRKR
Market
Shares outstanding
145.34M
Market cap
$9.71B
Enterprise value
$10.84B
Valuations
Price to earnings (P/E)
24.31
Price to book (P/B)
6.5
Price to sales (P/S)
3.23
EV/EBIT
21.28
EV/EBITDA
17.1
EV/Sales
3.61
Earnings
Revenue
$3B
EBIT
$509.2M
EBITDA
$633.7M
Free cash flow
$182M
Per share
EPS
$2.75
Free cash flow per share
$1.25
Book value per share
$10.28
Revenue per share
$20.67
TBVPS
$22.76
Balance sheet
Total assets
$4.51B
Total liabilities
$3.06B
Debt
$1.46B
Equity
$1.42B
Working capital
$957.9M
Liquidity
Debt to equity
1.03
Current ratio
1.81
Quick ratio
0.78
Net debt/EBITDA
1.77
Margins
EBITDA margin
21.1%
Gross margin
50.2%
Net margin
13.4%
Operating margin
12.6%
Efficiency
Return on assets
9.8%
Return on equity
30.7%
Return on invested capital
17.5%
Return on capital employed
15.3%
Return on sales
17%
Dividend
Dividend yield
0.3%
DPS
$0.2
Payout ratio
7.3%

BRKR stock price

How has the Bruker stock price performed over time
Intraday
4.06%
1 week
8%
1 month
2.36%
1 year
-5.58%
YTD
-9.04%
QTD
4.75%

Financial performance

How have Bruker's revenue and profit performed over time
Revenue
$3B
Gross profit
$1.51B
Operating income
$379M
Net income
$401.6M
Gross margin
50.2%
Net margin
13.4%
The net income is up by 29% year-on-year but it has declined by 6% since the previous quarter
BRKR's operating margin is down by 28% YoY and by 14% QoQ
BRKR's operating income is down by 17% year-on-year and by 13% since the previous quarter
Bruker's revenue has increased by 14% YoY

Growth

What is Bruker's growth rate over time

Valuation

What is Bruker stock price valuation
BRKR P/E details
P/E
24.31
P/B
6.5
P/S
3.23
EV/EBIT
21.28
EV/EBITDA
17.1
EV/Sales
3.61
BRKR's price to earnings (P/E) is 38% lower than its 5-year quarterly average of 37.5 and 23% lower than its last 4 quarters average of 30.5
BRKR's EPS is up by 30% year-on-year but it is down by 6% since the previous quarter
The stock's price to book (P/B) is 30% less than its 5-year quarterly average of 8.9 and 24% less than its last 4 quarters average of 8.2
BRKR's equity is up by 20% YoY and by 2.8% QoQ
The stock's price to sales (P/S) is 20% less than its 5-year quarterly average of 3.9 and 20% less than its last 4 quarters average of 3.9
Bruker's revenue has increased by 14% YoY

Efficiency

How efficient is Bruker business performance
Bruker's return on invested capital has decreased by 13% QoQ
BRKR's return on assets is up by 11% year-on-year but it is down by 10% since the previous quarter
Bruker's return on equity has decreased by 10% QoQ but it has increased by 3.4% YoY
BRKR's return on sales is down by 8% since the previous quarter but it is up by 4.9% year-on-year

Dividends

What is BRKR's dividend history
Dividend details
DPS
$0.2
Dividend yield
0.3%
Payout ratio
7.3%
Recent dividends

Financial health

How did Bruker financials performed over time
BRKR's total assets is 47% greater than its total liabilities
The quick ratio has decreased by 24% YoY and by 12% from the previous quarter
BRKR's total assets is up by 20% year-on-year and by 6% since the previous quarter
Bruker's debt is 3.5% more than its equity
BRKR's equity is up by 20% YoY and by 2.8% QoQ
Bruker's debt has increased by 19% YoY and by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.